"We measured out various versions of pseudoviruses* that mimic the entry of different coronaviruses into cells. The conclusion is that in the form of droplets on exposed surfaces, IonFlow technology has a clear inhibition on viral entry already within 30 minutes," says Nuria Izquierdo Useros, Supervisor/PhD and the principal investigator of the study at IrsiCaixa. "Personally, I find this extremely interesting, and the potential of this technology to combat virus spreading should be further investigated. Not least in these times, and especially given that this technology attacks the viral entry process so viruses can no longer infect human cells."
IrsiCaixa is a leading center for research into infectious diseases, located in
"It is both stimulating and gratifying that we have now been able to supplement the previous in-depth study from
* The intention of the test was to assess the capacity of inhibiting viral entry of both SARS-1 and SARS-2 pseudoviruses, which is a proof of principle of the efficacy of this strategy against different coronaviruses. Pseudoviruses are manipulated in the laboratory to mimic viral entrance into cells just once and are considered ideal to test the
efficacy of antivirals, antibodies or strategies aimed at inhibiting viral entry.
For further information, please contact:
CEO
+46 (0)70 828 61 96
lars.liljeholm@lightair.com
About
Publication:
This information is such information that the company is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided, through the agency of the above contact person, for publication 2021-03-31 at
https://news.cision.com/lightair/r/lightair-ionflow-air-purifier-effectively-reduces-the-infectivity-of-viruses-that-mimic-coronaviruse,c3318215
https://mb.cision.com/Main/14919/3318215/1395863.pdf
(c) 2021 Cision. All rights reserved., source